Mesoblast MESO
NASDAQ MESO
$12.55 -0.28 (-2.18%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mesoblast (MESO) Non-Current Deffered Revenue (2015 - 2016)

Updated

Analysis

Mesoblast (MESO) Non-Current Deffered Revenue (2015 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Mesoblast 1.63 Bn 1.19 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 11.25 Mn
Dec 31, 2015 15.00 Mn
Sep 30, 2015 18.75 Mn
Jun 30, 2015 22.51 Mn
API Access

Mesoblast Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MESO&period=max&api_key=YOUR_API_KEY